Yseop Launches “Yseop Copilot,” the World’s Most Secure Digital Colleague for Scientific Writers NEW YORK, June 06, 2023 (GLOBE NEWSWIRE) -- Yseop, the world-leading AI software company and pioneer in Generative AI, today announced the launch of Yseop Copilot, the world’s most secure content...

Yseop’s AI-Powered Augmented Analyst Chosen by Lilly to Expedite the Drug Approval Process and Deploy Automation at Scale NEW YORK, May 18, 2022 (GLOBE NEWSWIRE) -- Yseop, a world-leading AI software company and pioneer in Natural Language Processing (NLP), today announced a strategic collaboration with Eli Lilly and...

Inside Science: Alzheimer's Drug Trials Keep Failing -- It May Be Because We Don't Understand the Disease WASHINGTON, D.C., March 13, 2018 (GLOBE NEWSWIRE) -- In a new story for Inside Science News Service, Joel Shurkin offers an intimate look at why Alzheimer's research is failing to help patients,...

Vyteris and Zealand Pharma Announce Agreement on Active Transdermal Patch for Peptide Drugs FAIR LAWN, NJ--(Marketwire - April 14, 2009) - Vyteris, Inc. (OTCBB: VYTR), developer of the first FDA-approved active transdermal drug delivery system and a leader in active transdermal drug...